Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

What Are Whales Doing With Roku

Someone with a lot of money to spend has taken a bearish stance on Roku (NASDAQ:ROKU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Meta Platforms Whale Trades Spotted

Meta Platforms Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Meta Platforms. Looking at options history for Meta Platforms (NASDAQ:FB) we detected 30 strange trades.

Here's How Much $100 Invested In Vicor 15 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Vicor 15 Years Ago Would Be Worth Today

Vicor (NASDAQ:VICR) has outperformed the market over the past 15 years by 5.26% on an annualized basis producing an average annual return of 13.2%. Currently, Vicor has a market capitalization of $2.83 billion.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

How To Attend SPAR Group Q4 2021 Earnings Conference Call

SPAR Group (NASDAQ:SGRP) will host a conference call at 11:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results.

How To Attend Kala Pharmaceuticals Q4 2021 Earnings Conference Call

Kala Pharmaceuticals (NASDAQ:KALA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Kala Pharmaceuticals (KALA) Conference Call Follow this link to access the live webcast.

BZ Chart Of The Day: Is The Nikola Rally Over?

Markets can have memories, which means there's a good chance the rally in Nikola Corporation (NASDAQ: NKLA) may be about to end.

Iterum Therapeutics Q4 2021 Earnings Conference Call On March 28, 2022 At 08:30 AM ET

Iterum Therapeutics (NASDAQ:ITRM) will host a conference call at 08:30 AM ET on March 28, 2022, to discuss Q4 2021 earnings results.

inkl

Read news from The Economist, FT, and more,
with one subscription

Read How Analysts Reacted To Google's Pact With Spotify

Read How Analysts Reacted To Google's Pact With Spotify

Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google decided to allow Spotify Technology SA (NYSE:SPOT) and other app developers to offer users an alternative third-party payment option alongside Google Play's option. KeyBanc analyst Justin Patterson saw the move as a win for digital content providers. He viewed alternative payment options as a happy compromise that calmed regulators and…

Here's Why Vicinity Motor Shares Are Falling

Here's Why Vicinity Motor Shares Are Falling

Vicinity Motor Corp (NASDAQ: VEV) shares are trading lower by 30.2% at $2.31 after the company announced a $12 million direct registered offering.

Why Are Titan Machinery Shares Trading Lower Today

Why Are Titan Machinery Shares Trading Lower Today

Titan Machinery Inc. (NASDAQ:TITN) reported fourth-quarter FY22 revenue growth of 16.2% year-on-year, to $507.59 million, missing the consensus of $524.6 million. Equipment sales increased by 16.7% % Y/Y, and Parts sales rose 17.3%. Revenue by Segments: Agriculture $346.33 million (+14.2% Y/Y), Construction $87.88 million (-1.1% Y/Y) and International $73.39 million (+64.4% Y/Y).…

Here's Why Trip.com Group Shares Are Rising

Here's Why Trip.com Group Shares Are Rising

Trip.com Group Ltd (NASDAQ: TCOM) shares are trading higher by 3.6% at $24.87 after the company reported better-than-expected fourth-quarter EPS and sales results.

Pinduoduo Whale Trades Spotted

Pinduoduo Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Pinduoduo. Looking at options history for Pinduoduo (NASDAQ:PDD) we detected 14 strange trades.

Here's How Much You Would Have Made Owning Okta Stock In The Last 5 Years

Here's How Much You Would Have Made Owning Okta Stock In The Last 5 Years

Okta (NASDAQ:OKTA) has outperformed the market over the past 5 years by 30.31% on an annualized basis producing an average annual return of 43.92%. Currently, Okta has a market capitalization of $22.73 billion.

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Analyzing Moderna Inc's Short Interest

Moderna Inc's (NASDAQ:MRNA) short percent of float has risen 7.66% since its last report. The company recently reported that it has 17.61 million shares sold short, which is 5.06% of all regular shares that are available for trading.

Delcath Systems's Earnings Outlook

Delcath Systems (NASDAQ:DCTH) is set to give its latest quarterly earnings report on Friday, 2022-03-25. Here's what investors need to know before the announcement. Analysts estimate that Delcath Systems will report an earnings per share (EPS) of $-1.01.

DXP Enterprises's Earnings Outlook

DXP Enterprises (NASDAQ:DXPE) is set to give its latest quarterly earnings report on Friday, 2022-03-25. Here's what investors need to know before the announcement. Analysts estimate that DXP Enterprises will report an earnings per share (EPS) of $0.14.

Earnings Preview For BRP

BRP (NASDAQ:DOOO) is set to give its latest quarterly earnings report on Friday, 2022-03-25. Here's what investors need to know before the announcement. Analysts estimate that BRP will report an earnings per share (EPS) of $2.00.

Get all your
news in one place.

100's of premium titles.
One news app.

Preview: An2 Therapeutics, Inc Set To IPO Tomorrow

AN2 Therapeutics, Inc (NASDAQ:ANTX) IPO will take place March, 25 on the NASDAQ exchange under the ticker ANTX. The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on September 21, 2022.

Homology Medicines's Return On Capital Employed Overview

Benzinga Pro data, Homology Medicines (NASDAQ:FIXX) reported Q4 sales of $802.00 thousand. Earnings fell to a loss of $33.58 million, resulting in a 9.72% decrease from last quarter.

Recursion Pharmaceuticals's Return On Capital Employed Insights

Recursion Pharmaceuticals (NASDAQ:RXRX) brought in sales totaling $2.53 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 36.91%, resulting in a loss of $64.93 million.

First Watch Restaurant Gr's Return on Invested Capital Overview

First Watch Restaurant Gr (NASDAQ:FWRG) brought in sales totaling $162.62 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 694.25%, resulting in a loss of $4.65 million.

First Advantage's Return On Capital Employed Overview

Pulled from Benzinga Pro data, First Advantage (NASDAQ:FA) showed a loss in earnings since Q3, totaling $15.38 million. Sales, on the other hand, increased by 10.2% to $212.53 million during Q4.

Why Are BiondVax Pharma Shares Gaining Today?

BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) has

Vicinity Motor Shares Nosedive After $12M Equity Offering

Vicinity Motor Corp (NASDAQ:VEV) has entered into definitive agreements with new and existing institutional and accredited investors for the purchase and sale of 4.44 million shares and warrants to buy 4.44 million shares. Each unit is priced at $2.70 per unit. The gross proceeds of the offering are expected to be $12 million.…

1 … 787 788 789 790

People

Justin Patterson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

B of A Securities

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play